(Q44081426)

29 November 2017

Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy (English)

1 reference

29 November 2017

Michael P Dubé

1

1 reference

29 November 2017

Dajun Qian

2

1 reference

29 November 2017

Hannah Edmondson-Melançon

3

1 reference

29 November 2017

Fred R Sattler

4

1 reference

29 November 2017

Diane Goodwin

5

1 reference

29 November 2017

Carmen Martinez

6

1 reference

29 November 2017

Vanessa Williams

7

1 reference

29 November 2017

Debra Johnson

8

1 reference

29 November 2017

Thomas A Buchanan

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

23 July 2002

1 reference

Clinical Infectious Diseases

29 November 2017

1 reference

29 November 2017

35

1 reference

29 November 2017

475-481

1 reference

29 November 2017

4

1 reference

Insulin resistance in HIV protease inhibitor-associated diabetes

29 November 2017

1 reference

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

21 January 2018

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

Metabolic effects of indinavir in healthy HIV-seronegative men

21 January 2018

1 reference

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

21 January 2018

1 reference

Disorders of glucose metabolism in patients infected with human immunodeficiency virus

21 January 2018

1 reference

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study

21 January 2018

1 reference

Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.

21 January 2018

1 reference

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

21 January 2018

1 reference

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

21 January 2018

1 reference

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.

21 January 2018

1 reference

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

21 January 2018

1 reference

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/341489

1 reference

29 November 2017

1 reference